Author:
Zong Pengyu,Feng Jianlin,Yue Zhichao,Wu Gongxiong,Sun Baonan,He Yanlin,Miller Barbara,Yu Albert S.,Su Zhongping,Mori Yasuo,Xie Jia,Yue Lixia
Abstract
SUMMARYExcitotoxicity caused by NMDA receptors (NMDARs) is a major cause of neuronal death in ischemic stroke. However, past efforts of directly targeting NMDARs have unfortunately failed in clinical ischemic stroke trials. Here we reveal an unexpected mechanism underlying NMDARs-mediated neurotoxicity, which leads to identification of a novel target and development of an effective therapeutic peptide for ischemic stroke. We show that NMDAR’s excitotoxicity upon ischemic insults is mediated by physical and functional coupling to TRPM2. The physical interaction of TRPM2 with NMDARs results in markedly increase in the surface expression of NMDARs, leading to enhanced NMDAR function and increased neuronal death. We identified a specific NMDAR-interacting domain on TRPM2, and developed a cell-permeable peptide to uncouple TRPM2-NMDARs. The disrupting-peptide protects neurons against ischemic injury in vitro and protects mice against ischemic stroke in vivo. These findings provide an unconventional strategy to eliminate excitotoxic neuronal death without directly targeting NMDARs.HIGHLIGHTSTRPM2 physically and functionally interacts with NMDARsInteraction of TRPM2 with NMDARs exacerbates NMDAR’s extrasynaptic excitotoxicity by increasing NMDAR’s surface expression during ischemic injuryTRPM2 recruits PKCγ to the interacting complexes to increase NMDAR’s surface expressionUncoupling the interaction between TRPM2 and NMDARs with a disrupting peptide (TAT-EE3) protects neurons against ischemic stroke in vitro and in vivoGRAPHIC ABSTRACTTRPM2 excerbates NMDAR’s excitotoxicity by physically and functionally interacting with NMDARs. The disrupting pipette TAT-EE3 protects neurons against ischemic injury in vitro and in vivo.
Publisher
Cold Spring Harbor Laboratory